Published in Geriatrics on January 01, 1981
Apathetic thyrotoxicosis: A distinctive clinical and laboratory entity. Ann Intern Med (1970) 1.93
Medium-chain triglycerides. N Engl J Med (1969) 1.64
Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab (1997) 1.55
Calcium metabolism in normal human pregnancy. J Clin Endocrinol Metab (1971) 1.55
Interrelationships of hyperinsulinism and hypertriglyceridemia in young patients with coronary heart disease. Circulation (1968) 1.25
Thyroid storm. A review of 22 episodes with special emphasis on the use of guanethidine. Arch Intern Med (1969) 1.18
The pharmacology of sulfonylureas. Am J Med (1981) 1.16
Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. J Clin Endocrinol Metab (1975) 1.15
Use of test strips with colour meter to measure blood-glucose. Lancet (1970) 0.96
Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology (1977) 0.94
Diazepam (Valium) and thyroid function: a double-blind, placebo controlled study in normal volunteers showing no drug effect. Am J Med Sci (1969) 0.94
Benign parotid enlargement in bulimia. Ann Intern Med (1980) 0.92
Fibrosing pseudotumor of the sella and parasellar area producing hypopituitarism and multiple cranial nerve palsies. Neurosurgery (1993) 0.91
Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care (1984) 0.89
Coexistence of diabetes mellitus, optic atrophy, and sensorineural deafness: case report. Ann Ophthalmol (1986) 0.88
Pseudomonas aeruginosa sepsis following retrograde cholangiopancreatography (ERCP). Dig Dis Sci (1982) 0.87
Motor nerve conduction in alcoholics. Q J Stud Alcohol (1966) 0.86
Periarticular bone remodeling in rheumatoid arthritis. Calcif Tissue Res (1968) 0.86
Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. J Lab Clin Med (1979) 0.85
Can osteoporosis be prevented? Geriatrics (1980) 0.84
The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects. J Clin Endocrinol Metab (1976) 0.84
Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins. J Clin Endocrinol Metab (1980) 0.83
Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma. Am J Med (1984) 0.83
Thyrotrophin-producing pituitary adenomas. J Neurosurg (1982) 0.83
RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma. Thyroid (1996) 0.83
The effects of physiologic amounts of simple sugars on lipoprotein, glucose, and insulin levels in normal subjects. Diabetes Care (1984) 0.83
Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia. Metabolism (1979) 0.82
Spurious elevations in glycosylated hemoglobin (HbA1) secondary to hypertriglyceridemia. Arch Intern Med (1982) 0.82
Silent pancreatic pseudocyst. An unusual cause of extrahepatic biliary obstruction. Am J Dig Dis (1975) 0.82
Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins. Metabolism (1980) 0.81
Inhibition of low-density lipoprotein oxidation by oral herbal mixtures Maharishi Amrit Kalash-4 and Maharishi Amrit Kalash-5 in hyperlipidemic patients. Am J Med Sci (1997) 0.81
Primary adrenal insufficiency manifesting as malignant lymphoma. Arch Intern Med (1983) 0.80
Treatment of severe familial hypertriglyceridemia during pregnancy with very-low-fat diet and n-3 fatty acids. Nutrition (1996) 0.80
Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients. J Clin Endocrinol Metab (1986) 0.80
Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus. J Pediatr (1979) 0.79
Thyrotoxicosis and a thyrotropin-secreting pituitary tumor causing unilateral exophthalmos. J Clin Endocrinol Metab (1981) 0.79
Primary hyperparathyroidism and anemia. Arch Intern Med (1976) 0.78
Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Am J Med (1979) 0.78
17 alpha-hydroxylase deficiency masquerading as primary hyperaldosteronism. Am J Med Sci (1990) 0.78
Inhibition of intestinal iron absorption by laundry starch. Gastroenterology (1976) 0.78
Thyroxine withdrawal in thyroid cancer. Ohio State Med J (1975) 0.78
Iodine-131 labeled anti-CEA antibodies uptake by Hürthle cell carcinoma. Clin Nucl Med (1985) 0.78
Premenstrual syndrome: concerns, controversies, and treatment. Am J Obstet Gynecol (1985) 0.78
Case report. Congestive heart failure complicating the hungry bone syndrome. Am J Med Sci (1976) 0.77
Letter: Acute pancreatitis due to procainamide-induced lupus erythematosus. Ann Intern Med (1975) 0.77
Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol. Ann Intern Med (1979) 0.77
Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump. JAMA (1982) 0.76
Metastatic pure papillary thyroid carcinoma presenting as a toxic hot nodule. Clin Nucl Med (1998) 0.76
The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man. Clin Endocrinol (Oxf) (1980) 0.76
Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Am J Med (1985) 0.76
Metastatic pheochromocytoma associated with multiple endocrine neoplasia syndrome type II. Arch Surg (1990) 0.76
Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. Br Med J (Clin Res Ed) (1986) 0.75
Indapamide. Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory diabetic patients. Arch Intern Med (1986) 0.75
Metoclopramide suppositories in the treatment of diabetic gastroparesis. Arch Intern Med (1986) 0.75
Chronic hyponatremia associated with diabetic amyotrophy. Arch Intern Med (1986) 0.75
Osteoporosis: its morbidity and prevention. Ohio State Med J (1980) 0.75
Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. J Clin Endocrinol Metab (1982) 0.75
Clinical features, diagnosis and management of insulinoma in 16 consecutive patients: cost-ineffectiveness of non-invasive imaging modalities. Ohio State Med J (1984) 0.75
Serum lipids and lipoprotein composition in spontaneously diabetic BB Wistar rats. J Lipid Res (1984) 0.75
A clinical pharmacologic comparison of glyhexamide, tolbutamide and chlorpropamide in the treatment of stable diabetes. Am J Med Sci (1967) 0.75
The use of continuous subcutaneous octreotide infusion in brittle type 1 diabetic patients. Diabet Med (1991) 0.75
Hazards in antihypertension therapy. Ann Intern Med (1977) 0.75
Osteoporosis in primary care. Ohio State Med J (1985) 0.75
The effects of carbohydrate-enriched meals on glucose turnover and metabolic clearance rates of glucose in type 2 diabetic patients. Diabetologia (1986) 0.75
Gastrin Responses to a test meal in patients with familial medullary thyroid carcinoma. J Clin Endocrinol Metab (1982) 0.75
Acute and chronic studies using a new oral hypoglycemic agent, glyburide. Metabolism (1971) 0.75
Unusual manifestations of cushing's syndrome in a multiple endocrine neoplasia type I kindred. Endocr Pract (2004) 0.75
Diabetic ketoacidosis. Heart Lung (1978) 0.75
Oral agents and the elderly diabetic. Geriatrics (1979) 0.75
Hypertensive crisis induced by eating in a patient with pheochromocytoma. J Clin Gastroenterol (1983) 0.75
Random dosage of 131-I in the treatment of hyperthyroidism: results of a prospective study. Am J Med Sci (1969) 0.75
More than one insulin injection per day improves control. Med Times (1980) 0.75
Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. Am J Med (1984) 0.75
Present status of the oral hypoglycemic agents. S D J Med (1973) 0.75
Hormone secreting pituitary tumors. Trans Assoc Life Insur Med Dir Am (1989) 0.75
Oral hypoglycemic agents for treatment of NIDDM. Geriatrics (1984) 0.75
The role of gastric inhibitory polypeptide in the augmented insulin response to sucrose. Diabetes Care (1983) 0.75
Ocular changes in Graves' disease. Ohio State Med J (1983) 0.75
Thyroid uptake of Tc-99m compromising in vivo RBC tagging. J Nucl Med (1981) 0.75
"Pseudo" renal failure after isopropyl alcohol intoxication. South Med J (1982) 0.75
Letter: Erythrocytosis and hypothyroidism. Ann Intern Med (1976) 0.75
The value of technetium Tc 99m pertechnetate thyroid scanning in the diagnosis of factitious thyrotoxicosis. Arch Intern Med (1982) 0.75
High density lipoprotein (HDL): a protective lipoprotein. Ohio State Med J (1980) 0.75
Pregnancy complicated by insulinoma. Am J Med Sci (1984) 0.75
Arrhythmia induced by a tricyclic antidepressant in a patient with undiagnosed mitral valve prolapse. Am J Psychiatry (1981) 0.75
Diabetes insipidus and breast cancer. South Med J (1982) 0.75
Serum lipoprotein responses during active and stable weight reduction in reproductive obese females. J Clin Endocrinol Metab (1982) 0.75
Solitary cold thyroid nodule: cost-ineffectiveness of ultrasonography. South Med J (1984) 0.75
Limitations in usefulness of single dose intermediate acting insulin: a rapid response pattern in some type I diabetics. Am J Med Sci (1983) 0.75
Clinical uses of human growth hormone. Ohio State Med J (1968) 0.75
Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care (1985) 0.75
The clinical basis for contemporary classification and management of the diabetes syndrome. Trans Assoc Life Insur Med Dir Am (1984) 0.75
Silent reversal of acromegaly: pituitary apoplexy resulting in panhypopituitarism. Ohio State Med J (1969) 0.75
Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent. Am J Med Sci (1985) 0.75
Primary hyperparathyroidism: analysis of 220 patients with special emphasis on familial hypocalciuric hypercalcemia. Heart Lung (1984) 0.75
Metrizamide cisternography in the investigation of the empty sella syndrome. Arch Intern Med (1981) 0.75
Letter: Thyrotoxic hypercalcemia, renal tubular acidosis, and pancreatitis. Ann Intern Med (1976) 0.75
Significance of spontaneous ketonuria and serum C-peptide levels in obese type II diabetic patients. Diabetes Care (1984) 0.75